Jump to Navigation

Facebook Connect

User login

NLA Endorses ACC's Updated Decision Pathway For Non-Statin Therapies

The National Lipid Association has endorsed the 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, published by the Journal of the American... read more

REVEAL Study Results Reaffirms Importance of Cholesterol and Heart Disease

The National Lipid Association (NLA) welcomes the results of the REVEAL trial which demonstrated that reductions in cholesterol levels with anacetrapib were associated with a reduction in cardiovascular events.

Are You Preparing for ABCL MOC?

The American Board of Clinical Lipidology (ABCL) Board of Directors has published a list of recommended reading for those preparing for maintenance of certification (MOC). If you’re studying for the exam, you can find a list of suggested reading at... read more

Foundation of the NLA Launches RADAR Campaign, Redesigns LearnYourLipids.com

The Foundation of the NLA launched its RADAR (RAre Disease AwarReness) campaign and redesigned website, learnyourlipids.com on Monday, July 31.

Click here for the full archive of NLA's featured stories



by Dr. Radut.